GMED Globus Medical Inc
- Stocks
- Healthcare
- NYSE: GMED
Price (delayed)
$59.95
Market cap
$8.1B
P/E Ratio
22.79
Dividend/share
N/A
EPS
$2.63
Enterprise value
$7.99B
Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing
Highlights
The EPS has surged by 93% since the previous quarter
The company's net income has surged by 92% QoQ
The debt has dropped by 77% year-on-year but it has increased by 31% since the previous quarter
GMED's quick ratio is up by 42% year-on-year but it is down by 24% since the previous quarter
Key stats
What are the main financial stats of GMED
Market
Valuations
Earnings
Shares outstanding
135.06M
Market cap
$8.1B
Enterprise value
$7.99B
Price to earnings (P/E)
22.79
Price to book (P/B)
1.89
Price to sales (P/S)
3.09
EV/EBIT
21.52
EV/EBITDA
12.42
EV/Sales
3.04
Revenue
$2.63B
Gross profit
$1.65B
Operating income
$281.49M
Net income
$356.65M
EBIT
$371.13M
EBITDA
$643.01M
Free cash flow
$527.43M
Per share
Balance sheet
Liquidity
EPS
$2.63
EPS diluted
$2.6
Free cash flow per share
$3.9
Book value per share
$31.73
Revenue per share
$19.43
TBVPS
$20.19
Total assets
$4.96B
Total liabilities
$665.41M
Debt
$121.1M
Equity
$4.3B
Working capital
$1.31B
Debt to equity
0.03
Current ratio
4.07
Quick ratio
1.98
Net debt/EBITDA
-0.17
Margins
Efficiency
Dividend
EBITDA margin
24.5%
Gross margin
62.8%
Net margin
13.6%
Operating margin
10.7%
Return on assets
7.1%
Return on equity
8.6%
Return on invested capital
19.1%
Return on capital employed
8.2%
Return on sales
14.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GMED stock price
How has the Globus Medical stock price performed over time
Intraday
-4.52%
1 week
10.87%
1 month
4.5%
1 year
-10.63%
YTD
-27.52%
QTD
1.58%
Financial performance
How have Globus Medical's revenue and profit performed over time
Revenue
$2.63B
Gross profit
$1.65B
Operating income
$281.49M
Net income
$356.65M
Gross margin
62.8%
Net margin
13.6%
The company's net income has surged by 92% QoQ
The net margin has surged by 84% since the previous quarter
The gross profit has grown by 24% YoY and by 8% from the previous quarter
Globus Medical's revenue has increased by 17% YoY and by 4.6% QoQ
Price vs fundamentals
How does GMED's price correlate with its fundamentals
Growth
What is Globus Medical's growth rate over time
Valuation
What is Globus Medical stock price valuation
P/E
22.79
P/B
1.89
P/S
3.09
EV/EBIT
21.52
EV/EBITDA
12.42
EV/Sales
3.04
The EPS has surged by 93% since the previous quarter
The P/E is 68% less than the last 4 quarters average of 75.1 and 62% less than the 5-year quarterly average of 63.3
The stock's P/B is 36% less than its 5-year quarterly average of 3.1 and 18% less than its last 4 quarters average of 2.4
GMED's equity is up by 8% year-on-year and by 5% since the previous quarter
GMED's P/S is 44% lower than its 5-year quarterly average of 5.8 and 17% lower than its last 4 quarters average of 3.9
Globus Medical's revenue has increased by 17% YoY and by 4.6% QoQ
Efficiency
How efficient is Globus Medical business performance
The ROA has soared by 92% since the previous quarter
Globus Medical's return on equity has surged by 87% QoQ
GMED's ROIC has soared by 55% since the previous quarter
The return on sales has surged by 52% since the previous quarter
Dividends
What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GMED.
Financial health
How did Globus Medical financials performed over time
Globus Medical's current ratio has surged by 68% YoY but it has decreased by 9% QoQ
GMED's quick ratio is up by 42% year-on-year but it is down by 24% since the previous quarter
The debt is 97% smaller than the equity
The debt has dropped by 77% year-on-year but it has increased by 31% since the previous quarter
The company's debt to equity has shrunk by 77% YoY but it has surged by 50% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.